 Jed Lampe
Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 CYP3A | 14 | 2024 | 88 | 5.020 |
Why?
| | Cytochrome P-450 Enzyme System | 12 | 2024 | 155 | 3.450 |
Why?
| | Cytochrome P-450 CYP3A Inhibitors | 5 | 2024 | 18 | 2.710 |
Why?
| | Pseudomonas aeruginosa | 2 | 2024 | 352 | 1.340 |
Why?
| | Dehydroepiandrosterone Sulfate | 3 | 2024 | 46 | 1.120 |
Why?
| | Clobetasol | 1 | 2024 | 7 | 0.920 |
Why?
| | Raloxifene Hydrochloride | 1 | 2024 | 15 | 0.890 |
Why?
| | Pharmaceutical Preparations | 3 | 2018 | 179 | 0.890 |
Why?
| | Ciprofloxacin | 1 | 2024 | 29 | 0.880 |
Why?
| | Oxidation-Reduction | 4 | 2024 | 1060 | 0.870 |
Why?
| | Nevirapine | 1 | 2023 | 17 | 0.850 |
Why?
| | Antiviral Agents | 3 | 2024 | 744 | 0.820 |
Why?
| | Archaeal Proteins | 4 | 2015 | 50 | 0.810 |
Why?
| | Fluorocarbons | 2 | 2023 | 117 | 0.810 |
Why?
| | Deuterium | 1 | 2023 | 99 | 0.800 |
Why?
| | Quinolones | 1 | 2024 | 137 | 0.780 |
Why?
| | Aloe | 1 | 2022 | 2 | 0.770 |
Why?
| | Aminophenols | 1 | 2024 | 156 | 0.770 |
Why?
| | Hydroxyeicosatetraenoic Acids | 1 | 2022 | 43 | 0.750 |
Why?
| | Fluoresceins | 1 | 2021 | 47 | 0.740 |
Why?
| | Lopinavir | 1 | 2021 | 30 | 0.710 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2021 | 184 | 0.700 |
Why?
| | Ritonavir | 1 | 2021 | 74 | 0.680 |
Why?
| | Growth and Development | 1 | 2019 | 7 | 0.640 |
Why?
| | Xenobiotics | 1 | 2019 | 32 | 0.630 |
Why?
| | Lanthanoid Series Elements | 1 | 2019 | 1 | 0.630 |
Why?
| | Premature Birth | 1 | 2023 | 333 | 0.610 |
Why?
| | Anti-Retroviral Agents | 1 | 2021 | 233 | 0.610 |
Why?
| | Octamer Transcription Factor-1 | 1 | 2018 | 5 | 0.600 |
Why?
| | Chelating Agents | 1 | 2019 | 75 | 0.600 |
Why?
| | Biological Products | 1 | 2022 | 216 | 0.600 |
Why?
| | Disease | 1 | 2019 | 98 | 0.590 |
Why?
| | Small Molecule Libraries | 1 | 2019 | 94 | 0.580 |
Why?
| | Microsomes, Liver | 3 | 2024 | 86 | 0.580 |
Why?
| | Sulfolobus acidocaldarius | 3 | 2015 | 4 | 0.540 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 2 | 2014 | 11 | 0.520 |
Why?
| | Ligands | 6 | 2018 | 664 | 0.520 |
Why?
| | Cystic Fibrosis | 2 | 2024 | 1114 | 0.480 |
Why?
| | Cytochromes b5 | 1 | 2014 | 2 | 0.460 |
Why?
| | Organic Cation Transporter 1 | 1 | 2014 | 1 | 0.440 |
Why?
| | Testosterone | 2 | 2017 | 409 | 0.430 |
Why?
| | Heme | 3 | 2023 | 78 | 0.420 |
Why?
| | Iron | 3 | 2023 | 313 | 0.410 |
Why?
| | Methyltyrosines | 2 | 2010 | 3 | 0.390 |
Why?
| | Serotonin | 1 | 2014 | 323 | 0.370 |
Why?
| | Oxazines | 2 | 2008 | 30 | 0.350 |
Why?
| | Kinetics | 4 | 2022 | 1670 | 0.320 |
Why?
| | Molecular Docking Simulation | 2 | 2022 | 114 | 0.320 |
Why?
| | Models, Molecular | 5 | 2018 | 1570 | 0.290 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2010 | 611 | 0.280 |
Why?
| | Chemical and Drug Induced Liver Injury | 2 | 2023 | 137 | 0.270 |
Why?
| | Humans | 20 | 2024 | 137585 | 0.260 |
Why?
| | Fetus | 2 | 2024 | 806 | 0.260 |
Why?
| | Protein Conformation | 4 | 2018 | 934 | 0.250 |
Why?
| | Hepatocytes | 3 | 2016 | 220 | 0.240 |
Why?
| | Amino Acids | 1 | 2008 | 497 | 0.230 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2024 | 48 | 0.220 |
Why?
| | Protein Binding | 5 | 2018 | 2224 | 0.220 |
Why?
| | Binding Sites | 5 | 2018 | 1303 | 0.220 |
Why?
| | Naphthalenes | 1 | 2024 | 60 | 0.220 |
Why?
| | Liver | 2 | 2023 | 1943 | 0.210 |
Why?
| | HEK293 Cells | 2 | 2018 | 730 | 0.210 |
Why?
| | HIV Reverse Transcriptase | 1 | 2023 | 31 | 0.210 |
Why?
| | Substrate Specificity | 2 | 2018 | 372 | 0.200 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2023 | 84 | 0.200 |
Why?
| | Maternal-Fetal Exchange | 1 | 2024 | 165 | 0.200 |
Why?
| | Cysteine | 3 | 2012 | 204 | 0.200 |
Why?
| | Dehydroepiandrosterone | 1 | 2023 | 51 | 0.200 |
Why?
| | Cephalexin | 1 | 2022 | 12 | 0.190 |
Why?
| | Hepacivirus | 1 | 2024 | 261 | 0.190 |
Why?
| | Molecular Structure | 1 | 2023 | 489 | 0.190 |
Why?
| | Tretinoin | 1 | 2023 | 123 | 0.190 |
Why?
| | Arachidonic Acid | 1 | 2022 | 120 | 0.180 |
Why?
| | Protease Inhibitors | 1 | 2022 | 107 | 0.180 |
Why?
| | Hepatitis C | 1 | 2024 | 271 | 0.180 |
Why?
| | Fatty Acids | 2 | 2022 | 443 | 0.170 |
Why?
| | Molecular Conformation | 1 | 2021 | 145 | 0.170 |
Why?
| | Pregnancy | 2 | 2024 | 6763 | 0.170 |
Why?
| | Base Sequence | 4 | 2019 | 2181 | 0.170 |
Why?
| | Drug Combinations | 1 | 2021 | 343 | 0.160 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 158 | 0.160 |
Why?
| | Vasodilator Agents | 1 | 2022 | 331 | 0.160 |
Why?
| | Fluorescent Dyes | 1 | 2021 | 321 | 0.160 |
Why?
| | Pseudomonas Infections | 1 | 2022 | 225 | 0.160 |
Why?
| | Birth Weight | 1 | 2023 | 516 | 0.160 |
Why?
| | Pentetic Acid | 1 | 2019 | 13 | 0.160 |
Why?
| | Water | 1 | 2023 | 460 | 0.160 |
Why?
| | Burns | 1 | 2023 | 325 | 0.150 |
Why?
| | Click Chemistry | 1 | 2019 | 49 | 0.150 |
Why?
| | Infant, Newborn | 2 | 2021 | 6079 | 0.150 |
Why?
| | Copper | 1 | 2019 | 104 | 0.150 |
Why?
| | Spectrometry, Fluorescence | 3 | 2008 | 168 | 0.150 |
Why?
| | Bacterial Proteins | 1 | 2024 | 879 | 0.140 |
Why?
| | Principal Component Analysis | 1 | 2018 | 195 | 0.140 |
Why?
| | Hydroxylation | 1 | 2017 | 39 | 0.140 |
Why?
| | Biotransformation | 1 | 2017 | 65 | 0.140 |
Why?
| | Stereoisomerism | 1 | 2017 | 96 | 0.140 |
Why?
| | Staphylococcal Infections | 1 | 2022 | 400 | 0.140 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1997 | 143 | 0.140 |
Why?
| | Allosteric Regulation | 2 | 2007 | 97 | 0.130 |
Why?
| | Transcriptome | 1 | 2023 | 971 | 0.130 |
Why?
| | Anti-HIV Agents | 1 | 2023 | 778 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2024 | 1809 | 0.130 |
Why?
| | Protein Transport | 1 | 2018 | 445 | 0.130 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2016 | 15 | 0.130 |
Why?
| | Caprylates | 1 | 2016 | 25 | 0.130 |
Why?
| | Catalytic Domain | 3 | 2015 | 207 | 0.120 |
Why?
| | Alkanesulfonic Acids | 1 | 2016 | 41 | 0.120 |
Why?
| | HIV-1 | 1 | 2021 | 864 | 0.110 |
Why?
| | Crystallography, X-Ray | 3 | 2015 | 476 | 0.110 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2007 | 597 | 0.110 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 3 | 2015 | 340 | 0.110 |
Why?
| | Gene Expression | 2 | 2016 | 1502 | 0.110 |
Why?
| | Neurotransmitter Agents | 1 | 2014 | 81 | 0.110 |
Why?
| | Serum Albumin | 1 | 2014 | 150 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 150 | 0.110 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.100 |
Why?
| | Norepinephrine | 1 | 2014 | 204 | 0.100 |
Why?
| | Protein Isoforms | 1 | 2014 | 404 | 0.100 |
Why?
| | Heme Oxygenase (Decyclizing) | 1 | 2012 | 22 | 0.100 |
Why?
| | Receptors, Progesterone | 1 | 2014 | 350 | 0.100 |
Why?
| | Animals | 6 | 2023 | 36940 | 0.090 |
Why?
| | Dopamine | 1 | 2014 | 303 | 0.090 |
Why?
| | Protein Folding | 1 | 2012 | 280 | 0.090 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2007 | 86 | 0.090 |
Why?
| | DNA | 1 | 1997 | 1459 | 0.090 |
Why?
| | Lauric Acids | 1 | 2010 | 4 | 0.080 |
Why?
| | Spectrophotometry | 1 | 2010 | 61 | 0.080 |
Why?
| | Erythromycin | 2 | 2006 | 25 | 0.080 |
Why?
| | Prospective Studies | 1 | 2022 | 7604 | 0.080 |
Why?
| | Catalysis | 1 | 2010 | 307 | 0.080 |
Why?
| | Acetaminophen | 1 | 2011 | 268 | 0.070 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 26 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2012 | 375 | 0.070 |
Why?
| | Bacteria | 2 | 2022 | 858 | 0.070 |
Why?
| | Naphthalenesulfonates | 1 | 2006 | 7 | 0.070 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 2006 | 10 | 0.070 |
Why?
| | Cells, Cultured | 1 | 2014 | 4193 | 0.060 |
Why?
| | Female | 3 | 2024 | 73304 | 0.060 |
Why?
| | HIV Infections | 1 | 2021 | 2836 | 0.060 |
Why?
| | Biomarkers | 1 | 2017 | 4149 | 0.060 |
Why?
| | Photoaffinity Labels | 1 | 2005 | 6 | 0.060 |
Why?
| | Molecular Probe Techniques | 1 | 2005 | 10 | 0.060 |
Why?
| | Barrett Esophagus | 1 | 2007 | 149 | 0.060 |
Why?
| | Quinolines | 1 | 2006 | 178 | 0.060 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2007 | 319 | 0.060 |
Why?
| | Tryptophan | 1 | 2006 | 183 | 0.060 |
Why?
| | Models, Chemical | 1 | 2006 | 263 | 0.060 |
Why?
| | Progesterone | 1 | 2006 | 254 | 0.060 |
Why?
| | Esophageal Neoplasms | 1 | 2007 | 321 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2900 | 0.050 |
Why?
| | Cephalothin | 1 | 2022 | 6 | 0.050 |
Why?
| | Oxacillin | 1 | 2022 | 6 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 11 | 0.050 |
Why?
| | Cefadroxil | 1 | 2022 | 10 | 0.050 |
Why?
| | Apoptosis | 1 | 2011 | 2553 | 0.050 |
Why?
| | Cefazolin | 1 | 2022 | 21 | 0.050 |
Why?
| | Protein Structure, Secondary | 2 | 2015 | 374 | 0.050 |
Why?
| | Adult | 2 | 2023 | 37929 | 0.050 |
Why?
| | Protein Structure, Tertiary | 2 | 2015 | 861 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2022 | 361 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2837 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2016 | 2833 | 0.040 |
Why?
| | Leishmania | 1 | 1999 | 3 | 0.040 |
Why?
| | RNA, Protozoan | 1 | 1999 | 60 | 0.040 |
Why?
| | Oligonucleotides, Antisense | 1 | 1999 | 112 | 0.040 |
Why?
| | Mutation | 1 | 2010 | 3958 | 0.040 |
Why?
| | Berberine Alkaloids | 1 | 1997 | 1 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2022 | 450 | 0.040 |
Why?
| | Chlorambucil | 1 | 1997 | 10 | 0.040 |
Why?
| | Alkylation | 1 | 1997 | 26 | 0.040 |
Why?
| | Base Composition | 1 | 1997 | 78 | 0.040 |
Why?
| | Exons | 1 | 1999 | 355 | 0.030 |
Why?
| | Guanosine | 1 | 1997 | 41 | 0.030 |
Why?
| | HLA-DQ beta-Chains | 1 | 1997 | 63 | 0.030 |
Why?
| | Hydrolysis | 1 | 1997 | 177 | 0.030 |
Why?
| | Guanine | 1 | 1997 | 79 | 0.030 |
Why?
| | HLA-DQ Antigens | 1 | 1997 | 181 | 0.030 |
Why?
| | Time Factors | 1 | 2007 | 6828 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 1997 | 217 | 0.030 |
Why?
| | Male | 4 | 2017 | 67762 | 0.030 |
Why?
| | Protein Biosynthesis | 1 | 1999 | 433 | 0.030 |
Why?
| | Mice | 3 | 2023 | 17787 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1774 | 0.030 |
Why?
| | Adenosine | 1 | 1997 | 225 | 0.030 |
Why?
| | Nucleic Acid Conformation | 1 | 1999 | 728 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 346 | 0.030 |
Why?
| | Amino Acid Substitution | 2 | 2006 | 307 | 0.030 |
Why?
| | Peptide Mapping | 1 | 2015 | 64 | 0.030 |
Why?
| | Structure-Activity Relationship | 2 | 2006 | 570 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2015 | 225 | 0.030 |
Why?
| | Protein Stability | 1 | 2015 | 176 | 0.030 |
Why?
| | Enzyme Activation | 2 | 2006 | 810 | 0.030 |
Why?
| | Imidazoles | 1 | 2015 | 238 | 0.030 |
Why?
| | Down-Regulation | 1 | 2016 | 657 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 452 | 0.030 |
Why?
| | Up-Regulation | 1 | 2016 | 843 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2012 | 81 | 0.020 |
Why?
| | Galactosamine | 1 | 2011 | 3 | 0.020 |
Why?
| | Carbon Isotopes | 1 | 2012 | 144 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2057 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1353 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 840 | 0.020 |
Why?
| | Endotoxins | 1 | 2011 | 220 | 0.020 |
Why?
| | Caspase 3 | 1 | 2011 | 246 | 0.020 |
Why?
| | Species Specificity | 1 | 2011 | 585 | 0.020 |
Why?
| | Fasting | 1 | 2011 | 281 | 0.020 |
Why?
| | Glutathione | 1 | 2011 | 356 | 0.020 |
Why?
| | Molecular Dynamics Simulation | 1 | 2011 | 213 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2016 | 2475 | 0.020 |
Why?
| | Ploidies | 1 | 2007 | 18 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 39 | 0.020 |
Why?
| | Receptor, IGF Type 1 | 1 | 2007 | 65 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 515 | 0.020 |
Why?
| | Enzyme Stability | 1 | 2006 | 70 | 0.020 |
Why?
| | Phenanthrenes | 1 | 2006 | 13 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1997 | 2129 | 0.020 |
Why?
| | Phenylalanine | 1 | 2006 | 68 | 0.020 |
Why?
| | Neutrophils | 1 | 2011 | 1238 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 660 | 0.010 |
Why?
| | Thermodynamics | 1 | 2006 | 407 | 0.010 |
Why?
| | Aged | 1 | 2023 | 23961 | 0.010 |
Why?
| | Genotype | 1 | 2007 | 1916 | 0.010 |
Why?
| | Child | 1 | 2022 | 21935 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2011 | 5757 | 0.010 |
Why?
| | Adenocarcinoma | 1 | 2007 | 940 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2007 | 2844 | 0.010 |
Why?
| | Disease Progression | 1 | 2007 | 2757 | 0.010 |
Why?
| | Thionucleotides | 1 | 1999 | 35 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 1999 | 523 | 0.010 |
Why?
| | Hot Temperature | 1 | 1999 | 391 | 0.010 |
Why?
| | Middle Aged | 1 | 2007 | 33479 | 0.000 |
Why?
|
|
Lampe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|